Revolutionizing Pain Management: An Interview with Ensysce Biosciences and Creighton University
New York, NY – March 3, 2025
Introducing Safer Opioids through “Clever Chemistry”
Today’s Marketplace (TMP) recently had the distinct pleasure of hosting a thought-provoking conversation between Dr. Lynn Kirkpatrick, the dynamic CEO of Ensysce Biosciences (ENSC), and Dr. Neel Pathak, DS, Program Director with Creighton University. The doctors graciously shared their insights on the ongoing issues with opioids for pain management and how Ensysce Biosciences is making strides to introduce safer opioids through a revolutionary approach known as “clever chemistry.”
The Opioid Crisis: A Global Concern
The opioid crisis has been a significant public health concern for decades, with countless lives lost due to accidental overdoses and substance abuse. According to the Centers for Disease Control and Prevention (CDC), more than 130 Americans die every day from an opioid overdose. The World Health Organization (WHO) reports that opioid use has increased dramatically worldwide, leading to a surge in opioid-related deaths.
Addressing the Root Cause: Safer Opioids through “Clever Chemistry”
Dr. Kirkpatrick and Dr. Pathak discussed how Ensysce Biosciences is addressing this critical issue by developing safer opioids using “clever chemistry.” This innovative approach involves creating opioids with specific molecular structures that are less prone to accidental overdose and abuse. By targeting the mu-opioid receptor in the brain, these new opioids aim to provide effective pain relief while minimizing the risks associated with traditional opioids.
The Impact on Individuals
For millions of individuals who suffer from chronic pain, the development of safer opioids could be a game-changer. These individuals will no longer have to choose between managing their pain and risking their health and well-being. The potential for reduced addiction and accidental overdoses offers hope for a more balanced and effective approach to pain management.
A Global Impact: Transforming Pain Management and Public Health
The impact of this groundbreaking research extends far beyond individual lives. Safer opioids have the potential to transform the healthcare landscape and public health initiatives on a global scale. With a reduced risk of addiction and overdose, these opioids could help curb the opioid crisis, saving countless lives and resources.
Innovation in Action: Ensysce Biosciences and Creighton University
Through their collaboration, Ensysce Biosciences and Creighton University are leading the charge in developing safer opioids through “clever chemistry.” Their work represents a significant step forward in addressing the opioid crisis and improving pain management for millions of individuals around the world.
Conclusion: A Brighter Future for Pain Management
As the conversation between Dr. Kirkpatrick and Dr. Pathak demonstrated, the future of pain management is bright. Through the innovative application of “clever chemistry,” Ensysce Biosciences and Creighton University are paving the way for safer, more effective opioids that offer hope to those suffering from chronic pain without compromising their health and well-being. This groundbreaking research represents a significant leap forward in addressing the opioid crisis and improving public health on a global scale.
- Ensysce Biosciences and Creighton University are collaborating to develop safer opioids using “clever chemistry.”
- These opioids target the mu-opioid receptor in the brain, providing effective pain relief while minimizing risks.
- The impact of this research extends far beyond individual lives, offering hope for a more balanced and effective approach to pain management on a global scale.
- The development of safer opioids has the potential to transform the healthcare landscape and public health initiatives.
